A subset of virus-specific CD161 T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.

Citation data:

Blood, ISSN: 1528-0020, Vol: 129, Issue: 6, Page: 740-758

Publication Year:
Usage 5
Abstract Views 5
Captures 9
Readers 9
Social Media 11
Tweets 11
Citations 3
Citation Indexes 3
Alsuliman, Abdullah, Muftuoglu, Muharrem, Khoder, Ahmad, Ahn, Yong-Oon, Basar, Rafet, Verneris, Michael R, Muranski, Pawel, Barrett, A John, Liu, Enli, Li, Li, Stringaris, Kate, Armstrong-James, Darius, Shaim, Hila, Kondo, Kayo, Imahashi, Nobuhiko, Andersson, Borje, Marin, David, Champlin, Richard E, Shpall, Elizabeth J, Rezvani, Katayoun Show More Hide
American Society of Hematology
Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, Medicine
Most Recent Tweet View All Tweets
article description
The establishment of long-lived pathogen-specific T cells is a fundamental property of the adaptive immune response. However, the mechanisms underlying long-term persistence of antigen-specific CD4 T cells are not well-defined. Here we identify a subset of memory CD4 T cells capable of effluxing cellular toxins, including rhodamine (Rho), through the multidrug efflux protein MDR1 (also known as P-glycoprotein and ABCB1). Drug-effluxing CD4 T cells were characterized as CD161CD95CD45RACD127CD28CD25 cells with a distinct chemokine profile and a Th1-polarized pro-inflammatory phenotype. CD4CD161Rho-effluxing T cells proliferated vigorously in response to stimulation with anti-CD3/CD28 beads and gave rise to CD161 progeny in vitro. These cells were also capable of self-renewal and maintained their phenotypic and functional characteristics when cultured with homeostatic cytokines. Multidrug-effluxing CD4CD161 T cells were enriched within the viral-specific Th1 repertoire of healthy donors and patients with acute myeloid leukemia (AML) and survived exposure to daunorubicin chemotherapy in vitro. Multidrug-effluxing CD4CD161 T cells also resisted chemotherapy-induced cytotoxicity in vivo and underwent significant expansion in AML patients rendered lymphopenic after chemotherapy, contributing to the repopulation of anti-CMV immunity. Finally, after influenza vaccination, the proportion of influenza-specific CD4 T cells coexpressing CD161 was significantly higher after 2 years compared with 4 weeks after immunization, suggesting CD161 is a marker for long-lived antigen-specific memory T cells. These findings suggest that CD4CD161 T cells with rapid efflux capacity contribute to the maintenance of viral-specific memory T cells. These data provide novel insights into mechanisms that preserve antiviral immunity in patients undergoing chemotherapy and have implications for the development of novel immunotherapeutic approaches.

This article has 0 Wikipedia mention.